Jennifer J Stamps1, Linda M Bartoshuk, Kenneth M Heilman. 1. Department of Neuroscience, The Clinical and Translational Science Institute, University of Florida, College of Medicine, Gainesville, FL, USA. Electronic address: jstamps@ufl.edu.
Abstract
BACKGROUND: The early diagnosis of Alzheimer's disease (AD) may help reduce disability, enhance quality of life, and aid clinical trials. Portions of olfactory cortex are the initial sites of AD pathology and patients with AD often have more degeneration of their left than right hemisphere. Since the olfactory epithelium projects mainly to the ipsilateral olfactory cortex, patients with AD may demonstrate an asymmetrical (left greater than right) decrement of odor detection sensitivity. This retrospective, case-control study assessed a quick olfactory test that may help diagnose AD. METHODS: Participants with probable AD (N=18), mild cognitive impairment (MCI, N=24), other causes of dementia (OD, N=26) and matched controls (OC, N=26) were tested, with closed eyes, for their ability to detect an odor, one nostril at a time. A container of 14g of peanut butter was opened, held medially at the bottom of a 30cm ruler, and moved up 1cm at a time during the participants' exhale. Upon odor detection, the distance between the subject's nostril and container was measured. RESULTS: The mean odor detection distance of AD patients' left nostril (5.1cm), and not their right (17.4cm), was significantly less (F(3,90)=22.28, p<0.0001) than the other groups. The mean, standard error, and 95% Confidence Interval of the L-R nostril odor detection difference (cm) for AD were -12.4±0.5, (-15.0,-9.8); for MCI were -1.9±1.2, (-4.2,0.4); for OD were 4.8±1.0, (2.6,6.9); and for OC were 0.0±1.4 (-2.2,2.1). CONCLUSION: This non-invasive and inexpensive left-right nostril odor detection test appears to be a sensitive and specific test for probable AD.
BACKGROUND: The early diagnosis of Alzheimer's disease (AD) may help reduce disability, enhance quality of life, and aid clinical trials. Portions of olfactory cortex are the initial sites of AD pathology and patients with AD often have more degeneration of their left than right hemisphere. Since the olfactory epithelium projects mainly to the ipsilateral olfactory cortex, patients with AD may demonstrate an asymmetrical (left greater than right) decrement of odor detection sensitivity. This retrospective, case-control study assessed a quick olfactory test that may help diagnose AD. METHODS:Participants with probable AD (N=18), mild cognitive impairment (MCI, N=24), other causes of dementia (OD, N=26) and matched controls (OC, N=26) were tested, with closed eyes, for their ability to detect an odor, one nostril at a time. A container of 14g of peanut butter was opened, held medially at the bottom of a 30cm ruler, and moved up 1cm at a time during the participants' exhale. Upon odor detection, the distance between the subject's nostril and container was measured. RESULTS: The mean odor detection distance of ADpatients' left nostril (5.1cm), and not their right (17.4cm), was significantly less (F(3,90)=22.28, p<0.0001) than the other groups. The mean, standard error, and 95% Confidence Interval of the L-R nostril odor detection difference (cm) for AD were -12.4±0.5, (-15.0,-9.8); for MCI were -1.9±1.2, (-4.2,0.4); for OD were 4.8±1.0, (2.6,6.9); and for OC were 0.0±1.4 (-2.2,2.1). CONCLUSION: This non-invasive and inexpensive left-right nostril odor detection test appears to be a sensitive and specific test for probable AD.
Authors: Hilleke E Hulshoff Pol; Ron Hijman; Cornelis A F Tulleken; Thea J Heeren; Nico Schneider; Jan M van Ree Journal: Neuropsychologia Date: 2002 Impact factor: 3.139
Authors: P J Moberg; G D Pearlson; L J Speedie; J R Lipsey; M E Strauss; S E Folstein Journal: J Clin Exp Neuropsychol Date: 1987-12 Impact factor: 2.475
Authors: A B Graves; J D Bowen; L Rajaram; W C McCormick; S M McCurry; G D Schellenberg; E B Larson Journal: Neurology Date: 1999-10-22 Impact factor: 9.910
Authors: David J Irwin; Corey T McMillan; Jon B Toledo; Steven E Arnold; Leslie M Shaw; Li-San Wang; Vivianna Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Murray Grossman Journal: Arch Neurol Date: 2012-08
Authors: William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström Journal: Ann Neurol Date: 2004-03 Impact factor: 10.422
Authors: Anders M Fjell; Inge K Amlien; Markus H Sneve; Håkon Grydeland; Christian K Tamnes; Tristan A Chaplin; Marcello G P Rosa; Kristine B Walhovd Journal: Cereb Cortex Date: 2014-03-21 Impact factor: 5.357
Authors: Jesse K Siegel; Kristen E Wroblewski; Martha K McClintock; Jayant M Pinto Journal: Int Forum Allergy Rhinol Date: 2019-07-31 Impact factor: 3.858
Authors: Chandrika Canugovi; Magdalena Misiak; Morten Scheibye-Knudsen; Deborah L Croteau; Mark P Mattson; Vilhelm A Bohr Journal: Neurobiol Aging Date: 2014-10-14 Impact factor: 4.673
Authors: Richard L Doty; Edgardo A Bayona; Daniel S Leon-Ariza; Juan Cuadros; Inna Chung; Britney Vazquez; Fidias E Leon-Sarmiento Journal: J Neurol Sci Date: 2014-03-19 Impact factor: 3.181
Authors: Rehman Zafar; Humaira Naureen; Muhammad Zubair; Khadija Shahid; Muhammad Saeed Jan; Samar Akhtar; Hammad Ahmad; Wajeeha Waseem; Ali Haider; Saqib Ali; Muhammad Tariq; Abdul Sadiq Journal: Drug Des Devel Ther Date: 2021-06-21 Impact factor: 4.162